12:00 AM
Feb 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

UMN Pharma, University of Tampere deal

The university's Vaccine Research Center granted UMN Pharma exclusive, worldwide rights to develop and commercialize a non-live injectable adjuvant-free...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >